Related references
Note: Only part of the references are listed.Chronic administration of Glucagon-like peptide-1 receptor agonists improves trabecular bone mass and architecture in ovariectomised mice
M. Pereira et al.
BONE (2015)
Double incretin receptor knock-out (DIRKO) mice present with alterations of trabecular and cortical micromorphology and bone strength
A. Mieczkowska et al.
OSTEOPOROSIS INTERNATIONAL (2015)
Exendin-4 stimulates islet cell replication via the IGF1 receptor activation of mTORC1/S6K1
Jianling Xie et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2014)
Mitogen-Activated Protein Kinase Pathways in Osteoblasts
Matthew B. Greenblatt et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 29 (2013)
Antidiabetic therapy effects on bone metabolism and fracture risk
A. Montagnani et al.
DIABETES OBESITY & METABOLISM (2013)
Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Prevents Osteopenia by Promoting Bone Formation and Suppressing Bone Resorption in Aged Ovariectomized Rats
Xue Ma et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
JNK signaling plays an important role in the effects of TNF-alpha and IL-1 beta on in vitro osteoblastic differentiation of cultured human periosteal-derived cells
Young-Sool Hah et al.
MOLECULAR BIOLOGY REPORTS (2013)
Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes
Ju-Young Kim et al.
LIFE SCIENCES (2013)
Ghrelin inhibits the apoptosis of MC3T3-E1 cells through ERK and AKT signaling pathway
Qiu-Hua Liang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Anti-inflammatory effects of exendin-4, a glucagon-like peptide-1 analog, on human peripheral lymphocytes in patients with type 2 diabetes
Lan He et al.
JOURNAL OF DIABETES INVESTIGATION (2013)
Exendin-4 upregulates the expression of Wnt-4, a novel regulator of pancreatic β-cell proliferation
Charlotte Heller et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
Intracellular Signals Mediating the Food Intake-Suppressive Effects of Hindbrain Glucagon-like Peptide-1 Receptor Activation
Matthew R. Hayes et al.
CELL METABOLISM (2011)
Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes
M. C. Bunck et al.
DIABETES OBESITY & METABOLISM (2011)
Diabetes and bone health: the relationship between diabetes and osteoporosis-associated fractures
Salila Kurra et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2011)
Prevalence of osteoporosis and vertebral fractures in postmenopausal women with type 2 diabetes mellitus and their relationship with duration of the disease and chronic complications
Maira Viegas et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2011)
GLP-1 and exendin-4 can reverse hyperlipidic-related osteopenia
Bernardo Nuche-Berenguer et al.
JOURNAL OF ENDOCRINOLOGY (2011)
Signaling and biological effects of glucagon-like peptide 1 on the differentiation of mesenchymal stem cells from human bone marrow
C. Sanz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
Presence of a Functional Receptor for GLP-1 in Osteoblastic Cells, Independent of the cAMP-Linked GLP-1 Receptor
Bernardo Nuche-Berenguer et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice
Matthew B. Greenblatt et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states
Bernardo Nuche-Berenguer et al.
REGULATORY PEPTIDES (2010)
Effect of GLP-1 Treatment on Bone Turnover in Normal, Type 2 Diabetic, and Insulin-Resistant States
Bernardo Nuche-Berenguer et al.
CALCIFIED TISSUE INTERNATIONAL (2009)
Identification and Functional Characterization of ERK/MAPK Phosphorylation Sites in the Runx2 Transcription Factor
Chunxi Ge et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
JNK Activity Is Essential for Atf4 Expression and Late-Stage Osteoblast Differentiation
Tetsuya Matsuguchi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
The Extrapancreatic Effects of Glucagon-Like Peptide-1 and Related Peptides
Rania Abu-Hamdah et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
The murine glucagon-like peptide-1 receptor is essential for control of bone resorption
Chizumi Yamada et al.
ENDOCRINOLOGY (2008)
Tigogenin inhibits adipocytic differentiation and induces osteoblastic differentiation in mouse bone marrow stromal cells
Hua Zhou et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2007)
Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development
Chunxi Ge et al.
JOURNAL OF CELL BIOLOGY (2007)
ERK1/2-activated de novo Mapkapk2 synthesis is essential for osteogenic growth peptide mitogenic signaling in osteoblastic cells
SM San Miguel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Effect of GLP-1 on glucose transport and its cell signalling in human myocytes
N González et al.
REGULATORY PEPTIDES (2005)
Role of gastrointestinal hormones in postprandial reduction of bone resorption
DB Henriksen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation
J Guicheux et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Protein kinase Cζ activation mediates glucagon-like peptide-1-induced pancreatic β-cell proliferation
J Buteau et al.
DIABETES (2001)
Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase
RK Jaiswal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
